Viewing StudyNCT00168779



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00168779
Status: COMPLETED
Last Update Posted: 2017-12-28
First Post: 2005-09-12

Brief Title: Randomized Double-Blind Placebo-Controlled Forced-Titration Comparing Telmisartan vs Valsartan Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-09
Start Date Type: None
Primary Completion Date: 2006-07
Primary Completion Date Type: ACTUAL
Completion Date: 2006-07
Completion Date Type: ACTUAL
First Submit Date: 2005-09-12
First Submit QC Date: September 12 2005
Study First Post Date: 2005-09-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-12-27
Last Update Post Date: 2017-12-28
Last Update Post Date Type: ACTUAL